Back to User profile » Dr Xiangyong Li

Paper published by Dr Xiangyong Li:


Case report

Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report

Zhou R, Song L, Zhang W, Shao L, Li X, Li X

OncoTargets and Therapy 2021, 14:2847-2851

Published Date: 28 April 2021